Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of clinically proven cardiovascular and neuro products, today announced that the newly released clinical study of BergaMet NA’s HERHEART(TM) product produced incredible results. In addition, the company announced the appointment of internationally renowned Dr. Nesochi Okeke-Igokwe MD., M.S to its medical advisory board to promote women’s health. “Cardiovascular disease is the number one cause of death for women in the United States,” said Duke Pitts, CEO of BergaMet NA. “HERHEART was specifically formulated to fill the void in heart health products specifically designed for women. Not only does HERHEART assist in metabolic syndrome challenges, it also provides continued support for women as they mature. There is no other product that focuses directly on women, combines natural ingredients, and has the clinical studies to confirm its effectiveness. We expect HERHEART to become one of our top selling products as it provides an exclusive market position.”
To view the full press release, visit https://ibn.fm/XeS5V
About Grey Cloak Tech Inc.
Grey Cloak Tech, through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company’s websites: www.GreyCloakTech.com, www.BergametNA.com, www.UBNutrients.com.
NOTE TO INVESTORS: The latest news and updates relating to GRCK are available in the company’s newsroom at http://ibn.fm/GRCK
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.